404 related articles for article (PubMed ID: 17633298)
1. Good manufacturing practice for immunological veterinary medicinal products.
Todd JI
Rev Sci Tech; 2007 Apr; 26(1):135-45. PubMed ID: 17633298
[TBL] [Abstract][Full Text] [Related]
2. Control of manufacture--principles and purposes.
Luff PR
Dev Biol Stand; 1992; 79():155-8. PubMed ID: 1286749
[TBL] [Abstract][Full Text] [Related]
3. Marketing authorization of veterinary medicinal products in Poland.
Sztabińska-Koncka H; Lewicki J
Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):129-33. PubMed ID: 9339489
[TBL] [Abstract][Full Text] [Related]
4. Presentation of the EEC directive (81/852)--quality.
Lee AM
Dev Biol Stand; 1992; 79():39-41. PubMed ID: 1286763
[TBL] [Abstract][Full Text] [Related]
5. Regulatory requirements for vaccine authorisation.
Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
[TBL] [Abstract][Full Text] [Related]
6. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
Vlietinck A; Pieters L; Apers S
Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
[TBL] [Abstract][Full Text] [Related]
7. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
Woodward KN
J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304
[TBL] [Abstract][Full Text] [Related]
8. Regulation of immunological veterinary medicinal products in the European Union.
Brunko P
Rev Sci Tech; 1995 Dec; 14(4):1133-41. PubMed ID: 8639951
[TBL] [Abstract][Full Text] [Related]
9. [Community requirements relating to drugs derived from human blood and plasma].
Brunko P
Ann Pharm Fr; 1994; 52(2):89-98. PubMed ID: 7944184
[TBL] [Abstract][Full Text] [Related]
10. Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union.
Woodward KN
Regul Toxicol Pharmacol; 2008 Feb; 50(1):114-28. PubMed ID: 18060673
[TBL] [Abstract][Full Text] [Related]
11. International harmonisation of regulatory requirements.
Holmes M; Hill RE
Rev Sci Tech; 2007 Aug; 26(2):415-20. PubMed ID: 17892161
[TBL] [Abstract][Full Text] [Related]
12. The American manufacturer's view on the EEC texts and harmonization.
Draayer HA; Hilsabeck LJ; Miller RH
Dev Biol Stand; 1992; 79():77-83. PubMed ID: 1286768
[TBL] [Abstract][Full Text] [Related]
13. [Veterinary drug legal situation for oral medication in animal facilities in Germany].
Buettner-Peter U
Dtsch Tierarztl Wochenschr; 2008 Aug; 115(8):308-11. PubMed ID: 18717059
[TBL] [Abstract][Full Text] [Related]
14. The reduction of the use of challenge testing to provide evidence of efficacy in tests of immunological veterinary medicinal products (IVMPs).
Webster CJ
Dev Biol Stand; 1996; 86():103-9. PubMed ID: 8785938
[No Abstract] [Full Text] [Related]
15. Residues from veterinary medicinal products, growth promoters and performance enhancers in food-producing animals: a European Union perspective.
Serratosa J; Blass A; Rigau B; Mongrell B; Rigau T; Tortadès M; Tolosa E; Aguilar C; Ribó O; Balagué J
Rev Sci Tech; 2006 Aug; 25(2):637-53. PubMed ID: 17094703
[TBL] [Abstract][Full Text] [Related]
16. Comparison of requirements in the European Union and United States of America for pre-clinical viral safety testing of veterinary vaccines.
Sheridan S; Coughlin J
Biologicals; 2010 May; 38(3):340-5. PubMed ID: 20400329
[TBL] [Abstract][Full Text] [Related]
17. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
18. Regulatory requirements for veterinary vaccine stability in the European Community.
Fawthrop D
Dev Biol Stand; 1996; 87():319-27. PubMed ID: 8854032
[TBL] [Abstract][Full Text] [Related]
19. FEDESA's point of view: quality, application to IVMPs (immunological veterinary medicinal products).
Soulebot JP
Dev Biol Stand; 1992; 79():201-11. PubMed ID: 1286759
[No Abstract] [Full Text] [Related]
20. Consistency as tool to support in vitro batch potency testing in GMP production.
Stirling C
Dev Biol (Basel); 2012; 134():115-8. PubMed ID: 22888603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
